Authors
Loading...
Review reveals multi-targeted antitumor mechanisms of histone deacetylase inhibitors in lymphoma, highlighting the need to decipher molecular pathways for broader cancer treatment.
New et al. (2012) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: